CD8A and neoplasm: It has been shown that a vaccine based on moDCs loaded with tumor lysate affects the tumor microenvironment (TME) and promotes the transformation of a “cold” tumor into a “hot” one through activation and infiltration of CD8+T-lymphocytes, but it also affects up-regulation of PD-L1 expression in patients with metastatic melanoma (31).